SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

Orca is seeing significant volatility and community buzz driven by its low circulating supply, leading to active speculation about potential short squeezes and large price expansions. Investors are closely tracking its performance alongside broader Solana ecosystem trends, with many debating entry points and speculating on future growth targets.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of the preliminary design for its Phase 3 trial of CAD-1005 for treating heparin-induced thrombocytopenia. While the community is discussing the potential registration path and upcoming clinical milestones, sentiment is polarized, with some investors optimistic about the pipeline progress while others express significant skepticism regarding the company's long-term financial stability and frequent use of stock offerings.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

Mullen's crypto token is trending as the community debates its origins and ties to the history of the Mullen Automotive stock, which faced significant controversy regarding dilutions and reverse splits. Investors are divided, with some promoting the token as a high-potential speculative play while many others dismiss it as a pump-and-dump scheme linked to previous corporate scandals.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS is seeing intense activity driven by a low-float, speculative AI-narrative, with traders actively monitoring its technical structure for potential squeeze setups. Community discussion centers on high volatility and the stock's sensitivity to momentum-based trading, as investors weigh the risks of dilution against the possibility of significant upside volatility.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

DOGI is gaining momentum as a leading DRC-20 token on the Dogecoin network, with community members emphasizing its connection to the Doginals ecosystem and upcoming platform utility. Investors are actively discussing the token's potential growth alongside other BRC-20 assets, citing increased transaction activity and the broader expansion of the memecoin sector as key drivers.

Envela Corp. engages in recycling and re-commerce services at the forefront of the circular economy. It operates through the following segments: Consumer and Commercial. The Consumer segment focuses on selling authenticated high-end luxury goods, including pre-owned and repurposed fine jewelry, diamonds, gemstones, luxury watches, and secondary market bullion. The Commercial segment provides solutions for de-manufacturing end-of-life electronic assets, reclaiming base and precious metals, and other saleable materials. The company was founded on September 16, 1965 and is headquartered in Irving, TX.

Envela Corp

Envela Corp is seeing increased community interest driven by its strategic expansion into the circular economy and robust performance in IT asset disposition services. Traders are highlighting the stock's strong relative strength and volume as it builds momentum, while noting its profile as a potential growth play within the small-cap sector.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing community attention as a key infrastructure project in the Base ecosystem, with investors closely watching its AI agent capabilities and ongoing platform developments. Traders are actively debating the coin's utility-driven long-term potential versus short-term volatility, while many remain focused on accumulation strategies during current market movements.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is currently facing significant market attention following an earnings report that featured a revenue miss, prompting intense debate among retail traders regarding its valuation and long-term profitability. While some investors remain optimistic about the company's expansion into new verticals and its aggressive growth strategy, community discussions are heavily polarized by concerns over intensifying competition, shifting consumer spending habits, and regulatory scrutiny surrounding gig economy labor practices.

Baby Doge Coin is a meme cryptocurrency designed to be deflationary and more scarce over time. All holders of Baby Doge will earn more baby doge that is automatically sent to your wallet by simply holding Baby Doge coins in your wallet. Watch the amount of baby doge grow in your wallet as baby doge coin holders automatically receive a 5% fee from every on chain transaction that happens on the Baby Doge ecosystem. The community receives more baby doge coins from the fees generated each transaction.

Baby Doge Coin

Baby Doge Coin is experiencing intense community speculation and bullish sentiment as traders anticipate potential listings on major U.S. exchanges and look for the coin to repeat the zero-dropping performance of other successful meme coins. Investors are actively debating the impact of upcoming exchange integration, supply burn mechanisms, and historical price patterns, fueling a high-energy environment for long-term holders.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is trending following a massive tax refund from the IRS that significantly boosted its cash liquidity, sparking active community discussion regarding a potential short squeeze given the stock's elevated short interest. Investors are closely debating the company's valuation against this new capital infusion while monitoring for further catalysts like potential CHIPS Act funding and growth in the AI data center sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Moderate Buy" by Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and seven ha...

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Crosses Above 50-Day Moving Average   - Here's Why

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Crosses Above 50 Day Moving Average - Should You Sell...

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that the...

Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight analysts that are covering the stock, Marketbeat Ratings reports...

Enanta Pharmaceuticals (NASDAQ:ENTA) Shares Pass Below 200 Day Moving Average - Should You Sell?

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Crosses Below Two Hundred Day Moving Average - Here's Why...

Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that...

Enanta Pharmaceuticals (NASDAQ:ENTA) Now Covered by Analysts at Rodman & Renshaw

Rodman & Renshaw started coverage on Enanta Pharmaceuticals in a research note on Thursday. They issued a "buy" rating and a $20.00 target price for the company...

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Crosses Below Two Hundred Day Moving Average   - What's Next?

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Passes Below 200 Day Moving Average - Time to Sell...

Enanta Pharmaceuticals Pitches RSV Phase 3 Plans, Expands Oral Immunology Pipeline at Citizens Conference

Enanta Pharmaceuticals (NASDAQ:ENTA) used a presentation at the Citizens Life Sciences Conference to outline its evolving pipeline strategy, highlighting late-stage ambitions in respiratory syncytial...

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.49	--	--	N/A
Q1 '26	-$0.77	-$0.42	45.29%	BEAT
Q4 '25	-$1.03	-$0.87	15.26%	BEAT
Q3 '25	-$0.90	-$0.85	5.56%	BEAT
Q2 '25	-$1.15	-$1.06	7.56%	BEAT

ENTA
Enanta Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ENTA News

ENTAEnanta Pharmaceuticals Inc